NewsBenzingaReported Earlier, Takeda Launches ORZEYFUL In Japan And China As First-In-Class Orexin Agonist For Narcolepsy Type 1, With US Launch Set For Next Month After DEA Scheduling Reported Earlier, Takeda Launches ORZEYFUL In Japan And China As First-In-Class Orexin Agonist For Narcolepsy Type 1, With US Launch Set For Next Month After DEA Scheduling Benzinga 2026.10.15 07:01 (GMT+0) Open on Benzinga Other news Important News from Last Night and This Morning (October 19–October 20) Stock Pickers Burned by the AI Boom Think Their Moment Has Finally Arrived Walmart’s Flipkart is quietly building a food delivery challenger in India Robotics AI Company Dream Labs Completes $90 Million Seed Round, Launches Robot Foundation Model API Elysium, an L2 network in the Hyperliquid ecosystem, to launch mainnet on November 9 ARK Invest buys about $8.1 million of CoreWeave stock, sells about $3.56 million of Palantir stock
